Reports; Reconciliation Payments. Subject to this Section 8.2 (Sharing of Development Costs), with respect to Development Costs incurred by the Parties in connection with the performance of activities under the Global Development Plan, within ​ days following the end of each Calendar Quarter during which any such Development Costs are incurred, each of ITEOS and GSK (as applicable), in accordance with its Accounting Standards, shall submit to the Financial Working Group a written report setting forth in reasonable detail all Development Costs incurred by each such Party over such Calendar Quarter, provided, however, that a preliminary estimate of the Development Costs, in a format agreed by the Financial Working Group, shall be provided by each of ITEOS and GSK by the ​ of each Calendar Quarter for purposes of financial statement close process. For clarity, such estimate may be based on forecasted numbers and the Parties agree that the final actual amounts may differ from this estimate. Within ​ Business Days following the receipt by the Financial Working Group of such written reports setting forth the actual amounts of Development Costs incurred by each Party, the Financial Working Group shall prepare and submit to each Party a written report setting forth in reasonable detail # the calculation of all such Development Costs incurred by both Parties over such Calendar Quarter and any deviations from the Global Development Budget, and # the calculation of the net amount owed by GSK to ITEOS or by ITEOS to GSK in order to ensure the appropriate sharing of such Development Costs in accordance with [Section 3.2.3] (Shared Development Costs). The Party that is due for reimbursement of Development Costs shall invoice the other Party within ​ Business Days of receipt of such report from the Financial Working Group. Such payments by one Party to reimburse the other Party’s expenditures for Development Costs shall be payable ​ days following receipt of the invoice. Any Development Costs incurred in excess of the agreed upon Global Development Budget in any Calendar Quarter will be subject to the terms set forth in [Section 8.2.2] (Overruns).

Reports; Payments. Within ​ after the end of each Calendar Quarter during which there are sales of Licensed Product in the Licensed Territory giving rise to a payment obligation under [Section 6.4], # VFMCRP shall submit to Cara a report listing the total Net Sales for Licensed Product for each country in the Licensed Territory for such Calendar Quarter, ​ Confidential Treatment Requested the calculation of royalties owed (including listing the deductions taken from gross sales to arrive at Net Sales), and the royalties payable to Cara under [Section 6.3], including the basis for any adjustments taken under [Sections 6.3(c) or (d), and (b)])])] VFMCRP shall pay to Cara the royalties owed under [Section 6.3] on the date such report is due. Within ​ after the end of each Calendar Year during which there are sales by Cara of Licensed Product in the U.S. that are FMC Clinic Sales (as defined in [Section 6.5] above) giving rise to a payment obligation under [Section 6.5], # Cara shall submit to VFMCRP a report listing the total Net Sales for such FMC Clinic Sales for such Calendar Year, the calculation of COGS for the Licensed Product sold, and the share of the resulting Net Profit that is payable to VFMCRP under [Section 6.5], and # Cara shall pay to VFMCRP the share of such Net Profit owed under [Section 6.5] on the date such report is due.

Until the expiration of each Party’s royalty payment obligations under this Article 6, such Party shall make written reports to the other Party within forty-five (45) days after the end of each Calendar Quarter covering sales of Licensed Products on a product-by-product and country-by-country basis in the applicable part of the Territory by such Party, its Affiliates and Sublicensees during such Calendar Quarter. The information contained in each report under this [Section 6.6] shall be considered Confidential Information of the reporting Party.

Reports; Payments. Within ten (10) days of the end of each Calendar Quarter, AGTC shall deliver to LICENSEE a report setting forth the royalty rates, if any, that are payable to the Existing Licensors pursuant to the Existing License Agreements for each item of ​ Manufacturing Technology. Within sixty (60) days of the end of each Calendar Quarter, at any time during the Term in which LICENSEE is making royalty payments to AGTC for any Products under [Section 5.4, LICENSEE] shall deliver to AGTC a report setting forth for the most recently completed Calendar Quarter, the following information, on a Product-by-Product, country-by-country and Territory-wide basis: # Net Sales of each such Product, # the basis for any adjustments to the royalty payable for the sale of any such Product and # the royalty due hereunder for the sale of each such Product. No such reports shall be due for any such Product before the First Commercial Sale of such Product. The total royalty due for the sale of all such Products during such Calendar Quarter shall be remitted at the time such report is made.

Reports; Payments. Within ten (10) business days of the occurrence of any event which would trigger a milestone payment according to [Section 7.3 or 7.4]4], Biogen Idec shall inform Sunesis of such occurrence. The corresponding payment shall be due thirty (30) days after the occurrence of such event.

Reports; Payments. Within ​ days after the end of each ​ during which there are Net Sales giving rise to a payment obligation under [Section 6.4 or 6.5]5],

Payments; Reports. All payments due from a Party under [Sections 5.3 and 5.4]4] will be calculated and reported to the other Party for each calendar quarter within thirty (30) days following the end of the applicable calendar quarter. Each Royalty Payment will include a report by Relief detailing the Net Sales in the Relief Territory for the applicable calendar quarter with reasonable detail regarding the basis of the payment made, including, on a country-by-country basis, the volume of Product sold, the gross sales and Net Sales of Product, the amount payable, the method used to calculate such amount and the exchange rates used. Each Net Profit Payment will include a report by Acer detailing the Net Profits in the Acer Territory for the applicable calendar quarter with reasonable detail regarding the basis of the payment made, including, on a country-by-country basis, the volume of Product sold, applicable Net Sales, Cost of Sales, Development Costs, Distribution Costs, Marketing Costs, Other Operating Expense, Other Costs and Sales Costs, the amount payable, the method used to calculate the such amounts and the exchange rates used.

Reports; Payments. Within sixty (60) days after the end of each Calendar Quarter during which there are Net Sales giving rise to a payment under [Section 4.2], TransTech shall cause to be submitted to Novo a report, providing, with respect to each Licensed Product with Commercial sales, in reasonable detail an accounting of all Net Sales in each country in the Territory made during such Calendar Quarter. Concurrently with each such report, TransTech shall pay to Novo all royalties and sales milestones payable by it with respect to activities in such Calendar Quarter under [Sections 4.1 and 4.2].

Reports; Payments. Within ​ days after the end of each ​ during which there are Net Sales giving rise to a payment obligation under [Section 6.4 or 6.5]5], Huadong shall submit to vTv a report identifying, for each Product, the Net Sales for such Product for each Region in the Territory for such ​, any sales milestone and royalty payable to vTv and the basis for any reduction in royalties pursuant to any subsection of [Section 6.5]. Concurrently with each such report, Huadong shall pay to vTv all sales milestones and royalties payable by it under [Sections 6.4 and 6.5]5]. In addition, within ​ days after the end of each ​, Huadong shall deliver to vTv a report in a form mutually agreeable to both Parties detailing Net Sales and Adjusted Net Sales on a Product-by-Product and Region-by-Region basis. It is agreed by Huadong and vTv that if Huadong is required to report the sales of a Product on a ​ basis in a Region under the applicable Laws, then the reporting and payment obligations with respect to such Product under this [Section 6.6] shall be changed from reporting and payment for each ​ to reporting and payment for each ​,

Reports and Payments. Licensee shall notify Licensor in writing within ​ days after Licensee first learns of the achievement of each milestone set out in Article 6.2 (and with respect to sales related milestones, following ​) by Licensee, or any of its Affiliates or Sublicensees. The corresponding milestone payment shall be due within ​ days of receipt by Licensee of an invoice from Licensor and issued no earlier than the notice of achievement of the corresponding milestone event. Any payment made in accordance with Article 6.2 shall be non-refundable, non-creditable and non-cancellable, subject to [Section 12.6(ii)].